Green tea ointment launched for genital warts

Catephen is a herbal medicinal product licensed for the treatment of external genital and perianal warts (condylomata acuminata).

Catephen is applied three times daily for up to 16 weeks.
Catephen is applied three times daily for up to 16 weeks.

Catephen ointment contains 10% green trea (Camellia sinensis) leaf extract, corresponding to 55–72mg epigallocatechin gallate per gram.

Green tea leaf extract inhibits the growth of activated keratinocytes and has local antioxidant effects; however, its mechanism of action in the treatment of genital warts is unknown.

Three times daily

Further information
View Catephen drug record 
Summary of Product Characteristics
Manufacturer: Kora Healthcare

A 0.5cm strand of Catephen should be squeezed from the tube and applied to all external genital and anal warts three times daily for up to 16 weeks. If complete clearance of warts occurs before this time, treatment should stop. Even if new warts appear during treatment, the maximum 16-week recommendation should not be exceeded.

Female patients with warts in the vulvar region and uncircumcised males should apply the ointment with caution. Patients should be made aware that Catephen may weaken condoms and vaginal diaphragms and advised to wash off any ointment before sexual activity.

Complete clearance

Safety and efficacy of the ointment were assessed in two randomised, double-blind pivotal phase III studies in immunocompetent patients (n=502 and n=503).

Pooled analysis showed that treatment with the 10% green tea leaf extract applied three times daily for up to 16 weeks was significantly more effective than vehicle placebo in the treatment of external genital and perianal warts, as measured by rates of complete visual clearance of all warts (53.6% vs 35.4%, p<0.001). Active treatment was associated with a two-fold higher likelihood of complete wart clearance (odds ratio 2.10, 95% CI 1.49–2.98).

The difference in clearance rates reached significance at 6 weeks and the overall time to complete clearance was significantly shorter with active treatment than placebo (p<0.01).

Partial (at least 50%) clearance was observed in 76.0% of patients treated with the green tea leaf ointment compared with 52.2% of those using placebo.

Recurrence of warts in patients who achieved complete clearance did not differ significantly between the active treatment and placebo groups, occurring in 6.5% and 5.8% of patients, respectively.

Local reactions

The most commonly reported adverse effects of the green tea leaf ointment are local application site reactions, including pain, pruritus and oedema. Mild skin reactions should not lead to discontinuation of the product.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

MIMS Product Slides

Product overviews prepared by the MIMS team, in a handy slide format.

Click here

Slides are initiated, funded & reviewed by the companies specified.

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases